Resources and Insights

Exploration of Nitromethane-Carbonylation Strategy

Read this recently published Journal of Chemistry paper discussing how WuXi STA scientists and their partner AstraZeneca collaborated to improve...

Enzyme-Catalyzed Enantioselective Hydrolysis of 3-Substituent-2,6-piperidinedione an Important Approach to Preparation of Chiral Key Building Block of PROTACs

Case Study: Accelerate Commercial Manufacturing of an Oligonucleotide Adjuvant with WuXi Speed

Discover how WuXi STA helped a biotech company accelerate commercial manufacturing of an oligonucleotide adjuvant, meeting strict quality standards and...

Scaled-up Production of High Drug Loading and Dissolution Enabling Lumefantrine Nanoparticles

Development of High Drug Loading Lipid Nanoparticle Formulations

Development of High Drug Loading Lipid Nanoparticle Formulations

Pave an Expressway to Phase I – Strategies that Accelerate Your Early Phase Programs

Case Study: A PROTAC Molecule from PCC to IND Submission in 13 Months

Securing New Drug Development by Establishing and Maintaining Phase-appropriate RSM Designation from Development to Commercial Launch

Process development runs through the entire life cycle of new drug development and plays important roles in each stage.

Fully Automatic Parenteral Formulation Manufacturing Line